![]() |
Volumn 28, Issue 4 I, 1998, Pages 1161-1165
|
Hepatocellular carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
AFLATOXIN B;
ALCOHOL;
ALPHA 1 ANTITRYPSIN;
ALPHA FETOPROTEIN;
ALPHA INTERFERON;
AMINOTRANSFERASE;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CORE PROTEIN;
DNA;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FREE RADICAL;
GLUTATHIONE TRANSFERASE;
GLYCOGEN;
GLYCOPROTEIN P;
HEAT SHOCK PROTEIN;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
OLTIPRAZ;
ONCOPROTEIN;
POLYPRENOIC ACID;
PROTEIN P53;
TRANSFORMING GROWTH FACTOR;
ARTIFICIAL EMBOLISM;
CHEMOPROPHYLAXIS;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
COST;
DISEASE ASSOCIATION;
ECHOGRAPHY;
GENE;
HEPATITIS B;
HEPATITIS C;
HUMAN;
INCIDENCE;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MICROWAVE IRRADIATION;
MORTALITY;
NEOVASCULARIZATION (PATHOLOGY);
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PORTAL VEIN THROMBOSIS;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIOFREQUENCY;
RISK FACTOR;
SCREENING;
TUMOR VOLUME;
VACCINATION;
VIRUS HEPATITIS;
CARCINOMA, HEPATOCELLULAR;
ETHNIC GROUPS;
HUMANS;
INCIDENCE;
LIVER NEOPLASMS;
UNITED STATES;
|
EID: 0031711489
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510280436 Document Type: Conference Paper |
Times cited : (146)
|
References (8)
|